Research programme: infectious disease therapies - Functional GeneticsAlternative Names: FGI-345
Latest Information Update: 19 Jul 2010
At a glance
- Originator Functional Genetics
- Mechanism of Action HIV replication inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 28 Jul 2003 Preclinical trials in HIV-1 infections in USA (unspecified route)